| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,340,000,000 |
| Market
Cap: |
106.85(B) |
| Last
Volume: |
23,255,346 |
Avg
Vol: |
0 |
| 52
Week Range: |
$69.43 - $91.38 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 125 |
| Guru Rank Value : 7.5 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Medtronic is a medical technology, services and solutions company. Co.'s four operating and reportable segments are as follows: Cardiovascular Portfolio, which is made up of the cardiac rhythm and heart failure, structural heart and aortic, and coronary and peripheral vascular divisions; Medical Surgical Portfolio, which is made up of the surgical innovations and respiratory, gastrointestinal, and renal divisions; Neuroscience Portfolio is made up of the cranial and spinal technologies, specialty therapies, and neuromodulation divisions; and Diabetes Operating Unit, which develops, manufactures, and markets products and services for the management of Type 1 and Type 2 diabetes.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
31,549 |
36,546 |
56,412 |
75,447 |
| Total Sell Value |
$2,684,057 |
$3,094,660 |
$4,783,517 |
$6,318,268 |
| Total People Sold |
2 |
3 |
5 |
5 |
| Total Sell Transactions |
2 |
3 |
8 |
10 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kuntz Richard |
SVP & Chief Medical & Science |
• • – |
2021-11-05 |
4 |
D |
$122.98 |
$25,703 |
D/D |
(209) |
74,945 |
|
- |
|
| Wall Brett A. |
EVP & Pres Neuroscience |
• • – |
2021-11-05 |
4 |
D |
$122.98 |
$29,269 |
D/D |
(238) |
25,251 |
|
- |
|
| White Robert John |
EVP & Pres. Medical Surgical |
• • – |
2021-11-05 |
4 |
D |
$122.98 |
$30,253 |
D/D |
(246) |
46,648 |
|
- |
|
| Lerman Bradley E |
SVP General Counsel & Corp Sec |
• • – |
2021-11-05 |
4 |
D |
$122.98 |
$30,745 |
D/D |
(250) |
48,635 |
|
- |
|
| Ten Hoedt Rob |
EVP & President EMEA |
• • – |
2021-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
832 |
45,418 |
|
- |
|
| Parkhill Karen L |
EVP & Chief Financial Officer |
• • – |
2021-10-08 |
4 |
GA |
$0.00 |
$0 |
I/I |
12,000 |
49,859 |
|
- |
|
| Parkhill Karen L |
EVP & Chief Financial Officer |
• • – |
2021-10-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,000 |
35,974 |
|
- |
|
| Parkhill Karen L |
EVP & Chief Financial Officer |
• • – |
2021-10-06 |
4 |
GA |
$0.00 |
$0 |
I/I |
37,859 |
37,859 |
|
- |
|
| Parkhill Karen L |
EVP & Chief Financial Officer |
• • – |
2021-10-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
37,859 |
47,974 |
|
- |
|
| Lerman Bradley E |
SVP General Counsel & Corp Sec |
• • – |
2021-09-30 |
4 |
AS |
$126.58 |
$6,221,027 |
D/D |
(49,147) |
48,763 |
|
-16% |
|
| Lerman Bradley E |
SVP General Counsel & Corp Sec |
• • – |
2021-09-30 |
4 |
OE |
$78.00 |
$3,833,466 |
D/D |
49,147 |
97,910 |
|
- |
|
| Lerman Bradley E |
SVP General Counsel & Corp Sec |
• • – |
2021-08-31 |
4 |
AS |
$134.17 |
$6,812,482 |
D/D |
(50,775) |
48,763 |
|
-19% |
|
| Lerman Bradley E |
SVP General Counsel & Corp Sec |
• • – |
2021-08-31 |
4 |
OE |
$74.84 |
$3,800,001 |
D/D |
50,775 |
99,538 |
|
- |
|
| Martha Geoffrey |
CEO |
• • – |
2021-08-25 |
4 |
AS |
$132.67 |
$1,536,451 |
D/D |
(11,581) |
95,836 |
|
-21% |
|
| Martha Geoffrey |
CEO |
• • – |
2021-08-25 |
4 |
OE |
$55.32 |
$715,805 |
D/D |
11,581 |
105,936 |
|
- |
|
| Salmon Sean |
EVP & Pres Diabetes/Cardiovasc |
• • – |
2021-08-25 |
4 |
S |
$134.08 |
$3,810,492 |
D/D |
(28,419) |
33,329 |
|
21% |
|
| Salmon Sean |
EVP & Pres Diabetes/Cardiovasc |
• • – |
2021-08-25 |
4 |
OE |
$38.20 |
$1,100,066 |
D/D |
28,419 |
40,619 |
|
- |
|
| Martha Geoffrey |
CEO |
• • – |
2021-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
19,047 |
95,836 |
|
- |
|
| Martha Geoffrey |
CEO |
• • – |
2021-08-02 |
4 |
D |
$131.31 |
$715,640 |
D/D |
(5,450) |
76,789 |
|
- |
|
| Ten Hoedt Rob |
EVP & President EMEA |
• • – |
2021-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
4,419 |
44,489 |
|
- |
|
| Ten Hoedt Rob |
EVP & President EMEA |
• • – |
2021-08-02 |
4 |
D |
$131.31 |
$513,159 |
D/D |
(3,908) |
40,070 |
|
- |
|
| Parkhill Karen L |
EVP & Chief Financial Officer |
• • – |
2021-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,162 |
85,833 |
|
- |
|
| Parkhill Karen L |
EVP & Chief Financial Officer |
• • – |
2021-08-02 |
4 |
D |
$131.31 |
$898,029 |
D/D |
(6,839) |
78,671 |
|
- |
|
| White Robert John |
EVP & Pres. Medical Surgical |
• • – |
2021-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,095 |
46,769 |
|
- |
|
| White Robert John |
EVP & Pres. Medical Surgical |
• • – |
2021-08-02 |
4 |
D |
$131.31 |
$643,025 |
D/D |
(4,897) |
40,674 |
|
- |
|
681 Records found
|
|
Page 6 of 28 |
|
|
0.49 (0.62%) 
